{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:05:21Z","timestamp":1791813921119,"version":"4.3.4"},"reference-count":185,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T00:00:00Z","timestamp":1592006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Inflammation is a protective reaction activated in response to detrimental stimuli, such as dead cells, irritants or pathogens, by the evolutionarily conserved immune system and is regulated by the host. The inflammasomes are recognized as innate immune system sensors and receptors that manage the activation of caspase-1 and stimulate inflammation response. They have been associated with several inflammatory disorders. The NLRP3 inflammasome is the most well characterized. It is so called because NLRP3 belongs to the family of nucleotide-binding and oligomerization domain-like receptors (NLRs). Recent evidence has greatly improved our understanding of the mechanisms by which the NLRP3 inflammasome is activated. Additionally, increasing data in animal models, supported by human studies, strongly implicate the involvement of the inflammasome in the initiation or progression of disorders with a high impact on public health, such as metabolic pathologies (obesity, type 2 diabetes, atherosclerosis), cardiovascular diseases (ischemic and non-ischemic heart disease), inflammatory issues (liver diseases, inflammatory bowel diseases, gut microbiome, rheumatoid arthritis) and neurologic disorders (Parkinson\u2019s disease, Alzheimer\u2019s disease, multiple sclerosis, amyotrophic lateral sclerosis and other neurological disorders), compared to other molecular platforms. This review will provide a focus on the available knowledge about the NLRP3 inflammasome role in these pathologies and describe the balance between the activation of the harmful and beneficial inflammasome so that new therapies can be created for patients with these diseases.<\/jats:p>","DOI":"10.3390\/ijms21124223","type":"journal-article","created":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T03:17:32Z","timestamp":1592191052000},"page":"4223","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":283,"title":["Focus on the Role of NLRP3 Inflammasome in Diseases"],"prefix":"10.3390","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0223-1403","authenticated-orcid":false,"given":"Roberta","family":"Fusco","sequence":"first","affiliation":[{"name":"Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D\u2019Alcontres, n 31, 98166 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7868-2505","authenticated-orcid":false,"given":"Rosalba","family":"Siracusa","sequence":"additional","affiliation":[{"name":"Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D\u2019Alcontres, n 31, 98166 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Genovese","sequence":"additional","affiliation":[{"name":"Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D\u2019Alcontres, n 31, 98166 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6131-3690","authenticated-orcid":false,"given":"Salvatore","family":"Cuzzocrea","sequence":"additional","affiliation":[{"name":"Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D\u2019Alcontres, n 31, 98166 Messina, Italy"},{"name":"Department of Pharmacological and Physiological Science, Saint Louis University School of Medicine, 1402 South Grand Blvd, St. Louis, MO 63104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6725-8581","authenticated-orcid":false,"given":"Rosanna","family":"Di Paola","sequence":"additional","affiliation":[{"name":"Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D\u2019Alcontres, n 31, 98166 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,6,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"8041","DOI":"10.1073\/pnas.0611496104","article-title":"Cryopyrin\/NALP3 binds ATP\/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling","volume":"104","author":"Duncan","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: Mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nri3452","article-title":"Activation and regulation of the inflammasomes","volume":"13","author":"Latz","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.immuni.2013.05.016","article-title":"K(+) efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter","volume":"38","author":"Kuffa","year":"2013","journal-title":"Immunity"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4049\/jimmunol.0901363","article-title":"Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression","volume":"183","author":"Bauernfeind","year":"2009","journal-title":"J. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fimmu.2017.00036","article-title":"Canonical and Non-Canonical Activation of NLRP3 Inflammasome at the Crossroad between Immune Tolerance and Intestinal Inflammation","volume":"8","author":"Pellegrini","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nrd.2018.97","article-title":"Targeting the NLRP3 inflammasome in inflammatory diseases","volume":"17","author":"Mangan","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00011-013-0667-3","article-title":"OxLDL-induced IL-1 beta secretion promoting foam cells formation was mainly via CD36 mediated ROS production leading to NLRP3 inflammasome activation","volume":"63","author":"Liu","year":"2014","journal-title":"Inflamm. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1038\/srep07281","article-title":"Activation of NLRP3 inflammasome by crystalline structures via cell surface contact","volume":"4","author":"Hari","year":"2014","journal-title":"Sci. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/annrheumdis-2014-206074","article-title":"AMP-activated protein kinase suppresses urate crystal-induced inflammation and transduces colchicine effects in macrophages","volume":"75","author":"Wang","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.4049\/jimmunol.1400974","article-title":"Phosphocholine-Modified Macromolecules and Canonical Nicotinic Agonists Inhibit ATP-Induced IL-1beta Release","volume":"195","author":"Hecker","year":"2015","journal-title":"J. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/cvr\/cvt091","article-title":"The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury","volume":"99","author":"Sandanger","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.mib.2013.04.004","article-title":"Inflammasome-mediated pyroptotic and apoptotic cell death, and defense against infection","volume":"16","author":"Aachoui","year":"2013","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s13238-012-2118-2","article-title":"Regulation of HMGB1 release by inflammasomes","volume":"4","author":"Lu","year":"2013","journal-title":"Protein Cell"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12031-007-0012-9","article-title":"Origins and effects of extracellular alpha-synuclein: Implications in Parkinson\u2019s disease","volume":"34","author":"Lee","year":"2008","journal-title":"J. Mol. Neurosci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"20167","DOI":"10.1074\/jbc.M115.652321","article-title":"Caspase-8 as an Effector and Regulator of NLRP3 Inflammasome Signaling","volume":"290","author":"Antonopoulos","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4962","DOI":"10.4049\/jimmunol.1500865","article-title":"Internalized Cryptococcus neoformans Activates the Canonical Caspase-1 and the Noncanonical Caspase-8 Inflammasomes","volume":"195","author":"Chen","year":"2015","journal-title":"J. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/ni.2222","article-title":"Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1beta via a noncanonical caspase-8 inflammasome","volume":"13","author":"Gringhuis","year":"2012","journal-title":"Nat. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/cdd.2016.14","article-title":"NLRP3 regulates a non-canonical platform for caspase-8 activation during epithelial cell apoptosis","volume":"23","author":"Chung","year":"2016","journal-title":"Cell Death Differ."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.4049\/jimmunol.1302839","article-title":"FADD and caspase-8 mediate priming and activation of the canonical and noncanonical Nlrp3 inflammasomes","volume":"192","author":"Gurung","year":"2014","journal-title":"J. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.cell.2014.04.007","article-title":"Mechanisms and functions of inflammasomes","volume":"157","author":"Lamkanfi","year":"2014","journal-title":"Cell"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e3074","DOI":"10.1038\/cddis.2017.470","article-title":"NLRP3 inflammasome activation contributes to VSMC phenotypic transformation and proliferation in hypertension","volume":"8","author":"Sun","year":"2017","journal-title":"Cell Death Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1749-6632.2000.tb06651.x","article-title":"Inflamm-aging. An evolutionary perspective on immunosenescence","volume":"908","author":"Franceschi","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/imr.12295","article-title":"Drivers of age-related inflammation and strategies for healthspan extension","volume":"265","author":"Goldberg","year":"2015","journal-title":"Immunol. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"D\u2019Amico, R., Fusco, R., Cordaro, M., Siracusa, R., Peritore, A.F., Gugliandolo, E., Crupi, R., Scuto, M., Cuzzocrea, S., and Di Paola, R. (2020). Modulation of NLRP3 Inflammasome through Formyl Peptide Receptor 1 (Fpr-1) Pathway as a New Therapeutic Target in Bronchiolitis Obliterans Syndrome. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21062144"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"31355","DOI":"10.18632\/oncotarget.25823","article-title":"Absence of formyl peptide receptor 1 causes endometriotic lesion regression in a mouse model of surgically-induced endometriosis","volume":"9","author":"Fusco","year":"2018","journal-title":"Oncotarget"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1096\/fj.201601349R","article-title":"Inhibition of inflammasome activation improves lung acute injury induced by carrageenan in a mouse model of pleurisy","volume":"31","author":"Fusco","year":"2017","journal-title":"FASEB J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/MCA.0000000000000255","article-title":"NLRP3 inflammasome in peripheral blood monocytes of acute coronary syndrome patients and its relationship with statins","volume":"26","author":"Altaf","year":"2015","journal-title":"Coron. Artery Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bcp.2014.08.013","article-title":"Free fatty acids as modulators of the NLRP3 inflammasome in obesity\/type 2 diabetes","volume":"92","author":"Esser","year":"2014","journal-title":"Biochem. Pharm."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.4161\/auto.29647","article-title":"Autophagy in microglia degrades extracellular beta-amyloid fibrils and regulates the NLRP3 inflammasome","volume":"10","author":"Cho","year":"2014","journal-title":"Autophagy"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/imr.12285","article-title":"NLRP3 at the interface of metabolism and inflammation","volume":"265","author":"Haneklaus","year":"2015","journal-title":"Immunol. Rev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"7360","DOI":"10.1038\/ncomms8360","article-title":"Bruton\u2019s tyrosine kinase is essential for NLRP3 inflammasome activation and contributes to ischaemic brain injury","volume":"6","author":"Ito","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0022-510X(02)00030-8","article-title":"Caspase-1 expression in multiple sclerosis plaques and cultured glial cells","volume":"197","author":"Ming","year":"2002","journal-title":"J. Neurol. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"ra38","DOI":"10.1126\/scisignal.2002767","article-title":"Interferon-beta therapy against EAE is effective only when development of the disease depends on the NLRP3 inflammasome","volume":"5","author":"Inoue","year":"2012","journal-title":"Sci. Signal"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.intimp.2014.12.009","article-title":"Asiatic acid ameliorates dextran sulfate sodium-induced murine experimental colitis via suppressing mitochondria-mediated NLRP3 inflammasome activation","volume":"24","author":"Guo","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/ng.285","article-title":"Common variants in the NLRP3 region contribute to Crohn\u2019s disease susceptibility","volume":"41","author":"Villani","year":"2009","journal-title":"Nat. Genet."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nri2925","article-title":"Type 2 diabetes as an inflammatory disease","volume":"11","author":"Donath","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nrm2391","article-title":"Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes","volume":"9","author":"Guilherme","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.mce.2014.06.018","article-title":"Transcriptome analysis of human adipocytes implicates the NOD-like receptor pathway in obesity-induced adipose inflammation","volume":"394","author":"Yin","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.cmet.2010.11.011","article-title":"The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity","volume":"12","author":"Stienstra","year":"2010","journal-title":"Cell Metab."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"15324","DOI":"10.1073\/pnas.1100255108","article-title":"Inflammasome is a central player in the induction of obesity and insulin resistance","volume":"108","author":"Stienstra","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ijo.2013.59","article-title":"Obesity development in caspase-1-deficient mice","volume":"38","author":"Wang","year":"2014","journal-title":"Int. J. Obes. (Lond.)"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nature11552","article-title":"Functional interactions between the gut microbiota and host metabolism","volume":"489","author":"Tremaroli","year":"2012","journal-title":"Nature"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nm1415","article-title":"Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance","volume":"12","author":"Netea","year":"2006","journal-title":"Nat. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1172\/JCI200319246","article-title":"Obesity is associated with macrophage accumulation in adipose tissue","volume":"112","author":"Weisberg","year":"2003","journal-title":"J. Clin. Invest."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.1073\/pnas.1301996110","article-title":"Role of caspase-1 in regulation of triglyceride metabolism","volume":"110","author":"Kotas","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.cmet.2012.07.003","article-title":"High-fat diet triggers inflammation-induced cleavage of SIRT1 in adipose tissue to promote metabolic dysfunction","volume":"16","author":"Chalkiadaki","year":"2012","journal-title":"Cell Metab."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/ni.2022","article-title":"Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling","volume":"12","author":"Wen","year":"2011","journal-title":"Nat. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.84.23.8628","article-title":"Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients","volume":"84","author":"Cooper","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.molcel.2014.03.029","article-title":"Inflammasomes and metabolic disorders: Old genes in modern diseases","volume":"54","author":"Robbins","year":"2014","journal-title":"Mol. Cell"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJMoa065213","article-title":"Interleukin-1-receptor antagonist in type 2 diabetes mellitus","volume":"356","author":"Larsen","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/nrendo.2009.271","article-title":"Blockade of interleukin 1 in type 1 diabetes mellitus","volume":"6","author":"Pickersgill","year":"2010","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Ferreira, N.S., Bruder-Nascimento, T., Pereira, C.A., Zanotto, C.Z., Prado, D.S., Silva, J.F., Rassi, D.M., Foss-Freitas, M.C., Alves-Filho, J.C., and Carlos, D. (2019). NLRP3 Inflammasome and Mineralocorticoid Receptors Are Associated with Vascular Dysfunction in Type 2 Diabetes Mellitus. Cells, 8.","DOI":"10.3390\/cells8121595"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2337\/db12-0420","article-title":"Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes","volume":"62","author":"Lee","year":"2013","journal-title":"Diabetes"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.2279","article-title":"The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance","volume":"17","author":"Vandanmagsar","year":"2011","journal-title":"Nat. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ni.1831","article-title":"Thioredoxin-interacting protein links oxidative stress to inflammasome activation","volume":"11","author":"Zhou","year":"2010","journal-title":"Nat. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cmet.2011.10.011","article-title":"The inflammasome puts obesity in the danger zone","volume":"15","author":"Stienstra","year":"2012","journal-title":"Cell Metab."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ni.1935","article-title":"Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes","volume":"11","author":"Masters","year":"2010","journal-title":"Nat. Immunol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"7283","DOI":"10.1073\/pnas.93.14.7283","article-title":"Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide","volume":"93","author":"Janson","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1172\/JCI200215318","article-title":"Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets","volume":"110","author":"Maedler","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/nm.3265","article-title":"Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes","volume":"19","author":"Jourdan","year":"2013","journal-title":"Nat. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.2337\/db14-1098","article-title":"Monounsaturated fatty acid-enriched high-fat diets impede adipose NLRP3 inflammasome-mediated IL-1beta secretion and insulin resistance despite obesity","volume":"64","author":"Finucane","year":"2015","journal-title":"Diabetes"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.immuni.2013.05.015","article-title":"Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation","volume":"38","author":"Yan","year":"2013","journal-title":"Immunity"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1083\/jcb.200903124","article-title":"Glyburide inhibits the Cryopyrin\/Nalp3 inflammasome","volume":"187","author":"Lamkanfi","year":"2009","journal-title":"J. Cell Biol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.2538","article-title":"Atherosclerosis: Current pathogenesis and therapeutic options","volume":"17","author":"Weber","year":"2011","journal-title":"Nat. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0008-6363(03)00343-2","article-title":"Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice","volume":"59","author":"Elhage","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"E41","DOI":"10.1161\/hh1901.098735","article-title":"Interleukin-18\/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability","volume":"89","author":"Mallat","year":"2001","journal-title":"Circ. Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.atherosclerosis.2009.07.053","article-title":"IL-18 overexpression promotes vascular inflammation and remodeling in a rat model of metabolic syndrome","volume":"208","author":"Tan","year":"2010","journal-title":"Atherosclerosis"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1161\/01.ATV.0000147126.99529.0a","article-title":"Overexpression of IL-18 decreases intimal collagen content and promotes a vulnerable plaque phenotype in apolipoprotein-E\u2013deficient mice","volume":"24","author":"Verkleij","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"81ps17","DOI":"10.1126\/scitranslmed.3001902","article-title":"The inflammasome in atherosclerosis and type 2 diabetes","volume":"3","author":"Masters","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ni.2639","article-title":"CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation","volume":"14","author":"Sheedy","year":"2013","journal-title":"Nat. Immunol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.ATV.0000064374.15232.C3","article-title":"Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice","volume":"23","author":"Kirii","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.atherosclerosis.2011.02.026","article-title":"Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice","volume":"216","author":"Bhaskar","year":"2011","journal-title":"Atherosclerosis"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/ni.2704","article-title":"Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1alpha and sterile vascular inflammation in atherosclerosis","volume":"14","author":"Freigang","year":"2013","journal-title":"Nat. Immunol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1038\/cddis.2011.18","article-title":"Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome","volume":"2","author":"Menu","year":"2011","journal-title":"Cell Death Dis."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/s41591-018-0124-5","article-title":"Interleukin-1beta has atheroprotective effects in advanced atherosclerotic lesions of mice","volume":"24","author":"Gomez","year":"2018","journal-title":"Nat. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1161\/CIRCULATIONAHA.116.024369","article-title":"NLRP3 Inflammasome Mediates Aldosterone-Induced Vascular Damage","volume":"134","author":"Ferreira","year":"2016","journal-title":"Circulation"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrcardio.2017.161","article-title":"The NLRP3 inflammasome in acute myocardial infarction","volume":"15","author":"Toldo","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/CIRCULATIONAHA.110.982777","article-title":"Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia\/reperfusion injury","volume":"123","author":"Kawaguchi","year":"2011","journal-title":"Circulation"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"791","DOI":"10.5114\/aoms.2014.44871","article-title":"NLRP3 and downstream cytokine expression elevated in the monocytes of patients with coronary artery disease","volume":"10","author":"Wang","year":"2014","journal-title":"Arch. Med. Sci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.bbrc.2015.12.051","article-title":"NLRP3 inflammasome activation during myocardial ischemia reperfusion is cardioprotective","volume":"469","author":"Sandanger","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ijcard.2014.09.148","article-title":"Nlrp3 plays no role in acute cardiac infarction due to low cardiac expression","volume":"177","author":"Jong","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ijcard.2016.02.043","article-title":"Inhibition of the NLRP3 inflammasome limits the inflammatory injury following myocardial ischemia-reperfusion in the mouse","volume":"209","author":"Toldo","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"9743280","DOI":"10.1155\/2017\/9743280","article-title":"NLRP3 Inflammasome Activation-Mediated Pyroptosis Aggravates Myocardial Ischemia\/Reperfusion Injury in Diabetic Rats","volume":"2017","author":"Qiu","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00395-014-0415-z","article-title":"TXNIP mediates NLRP3 inflammasome activation in cardiac microvascular endothelial cells as a novel mechanism in myocardial ischemia\/reperfusion injury","volume":"109","author":"Liu","year":"2014","journal-title":"Basic Res. Cardiol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3389\/fphys.2017.00519","article-title":"NLRP3 Inflammasome as a Molecular Marker in Diabetic Cardiomyopathy","volume":"8","author":"Luo","year":"2017","journal-title":"Front. Physiol."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Luo, B., Li, B., Wang, W., Liu, X., Xia, Y., Zhang, C., Zhang, M., Zhang, Y., and An, F. (2014). NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0104771"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1113\/expphysiol.2012.068338","article-title":"The Nlrp3 inflammasome promotes myocardial dysfunction in structural cardiomyopathy through interleukin-1beta","volume":"98","author":"Bracey","year":"2013","journal-title":"Exp. Physiol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.bbrc.2017.02.021","article-title":"Triptolide attenuates pressure overload-induced myocardial remodeling in mice via the inhibition of NLRP3 inflammasome expression","volume":"485","author":"Li","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Zhang, W., Xu, X., Kao, R., Mele, T., Kvietys, P., Martin, C.M., and Rui, T. (2014). Cardiac fibroblasts contribute to myocardial dysfunction in mice with sepsis: The role of NLRP3 inflammasome activation. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0107639"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"H1438","DOI":"10.1152\/ajpheart.00441.2014","article-title":"Involvement of NLRP3 inflammasome in CVB3-induced viral myocarditis","volume":"307","author":"Wang","year":"2014","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1096\/fj.201700761RR","article-title":"Effects of chronically increased VEGF-A on the aging heart","volume":"32","author":"Marneros","year":"2018","journal-title":"FASEB J."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1476-9255-9-49","article-title":"Expression analysis of inflammasomes in experimental models of inflammatory and fibrotic liver disease","volume":"9","author":"Boaru","year":"2012","journal-title":"J. Inflamm. (Lond.)"},{"key":"ref_95","first-page":"305","article-title":"Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome","volume":"119","author":"Imaeda","year":"2009","journal-title":"J. Clin. Investig."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.taap.2010.07.004","article-title":"Role of caspase-1 and interleukin-1beta in acetaminophen-induced hepatic inflammation and liver injury","volume":"247","author":"Williams","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1089\/hum.2010.145","article-title":"Gene silencing of NALP3 protects against liver ischemia-reperfusion injury in mice","volume":"22","author":"Zhu","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"641865","DOI":"10.1155\/2010\/641865","article-title":"The TLR4\/TRIF-Mediated Activation of NLRP3 Inflammasome Underlies Endotoxin-Induced Liver Injury in Mice","volume":"2010","author":"Tsutsui","year":"2010","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"20459","DOI":"10.1073\/pnas.1010337107","article-title":"Schistosoma mansoni triggers Dectin-2, which activates the Nlrp3 inflammasome and alters adaptive immune responses","volume":"107","author":"Ritter","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/hep.24341","article-title":"Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells","volume":"54","author":"Csak","year":"2011","journal-title":"Hepatology"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.3748\/wjg.v17.i43.4772","article-title":"Lipopolysaccharide induces and activates the Nalp3 inflammasome in the liver","volume":"17","author":"Ganz","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"12200","DOI":"10.1038\/s41598-017-11744-6","article-title":"Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD","volume":"7","author":"Pierantonelli","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nri3661","article-title":"Cytokines in inflammatory bowel disease","volume":"14","author":"Neurath","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"ref_104","first-page":"1297","article-title":"Monocyte and M1 Macrophage-induced Barrier Defect Contributes to Chronic Intestinal Inflammation in IBD","volume":"21","author":"Lissner","year":"2015","journal-title":"Inflamm. Bowel. Dis."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1084\/jem.20111453","article-title":"IL-1beta mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4(+) Th17 cells","volume":"209","author":"Coccia","year":"2012","journal-title":"J. Exp. Med."},{"key":"ref_106","first-page":"737","article-title":"The Pathogenic Role of NLRP3 Inflammasome Activation in Inflammatory Bowel Diseases of Both Mice and Humans","volume":"11","author":"Liu","year":"2017","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/ibd.21478","article-title":"NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis","volume":"17","author":"Hirota","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/mi.2014.1","article-title":"Inflammasome activation has an important role in the development of spontaneous colitis","volume":"7","author":"Zhang","year":"2014","journal-title":"Mucosal Immunol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1136\/gut.2009.197822","article-title":"Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome","volume":"59","author":"Bauer","year":"2010","journal-title":"Gut"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1124\/jpet.103.057059","article-title":"The interleukin-1 beta-converting enzyme inhibitor pralnacasan reduces dextran sulfate sodium-induced murine colitis and T helper 1 T-cell activation","volume":"308","author":"Loher","year":"2004","journal-title":"J. Pharm. Exp."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1007\/s10620-017-4609-8","article-title":"Activation of NLRP3 Inflammasome in Inflammatory Bowel Disease: Differences Between Crohn\u2019s Disease and Ulcerative Colitis","volume":"62","author":"Lazaridis","year":"2017","journal-title":"Dig. Dis. Sci."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/nyas.12458","article-title":"Mechanism of NLRP3 inflammasome activation","volume":"1319","author":"Sutterwala","year":"2014","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1021\/acs.jmedchem.6b01624","article-title":"Development of an Acrylate Derivative Targeting the NLRP3 Inflammasome for the Treatment of Inflammatory Bowel Disease","volume":"60","author":"Cocco","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.2174\/1381612823666170201162414","article-title":"NLRP3 Inhibitors as Potential Therapeutic Agents for Treatment of Inflammatory Bowel Disease","volume":"23","author":"Perera","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"8618","DOI":"10.1038\/s41598-018-26775-w","article-title":"MCC950, a specific small molecule inhibitor of NLRP3 inflammasome attenuates colonic inflammation in spontaneous colitis mice","volume":"8","author":"Perera","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.3389\/fphar.2018.01405","article-title":"A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation","volume":"9","author":"Pellegrini","year":"2018","journal-title":"Front. Pharm."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.immuni.2010.03.003","article-title":"The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis","volume":"32","author":"Zaki","year":"2010","journal-title":"Immunity"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12026-012-8265-y","article-title":"Complexity and dynamics of host-fungal interactions","volume":"53","author":"Cottier","year":"2012","journal-title":"Immunol. Res."},{"key":"ref_119","first-page":"323","article-title":"The role of intestinal microbiota and the immune system","volume":"17","author":"Purchiaroni","year":"2013","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"13780","DOI":"10.1073\/pnas.0706625104","article-title":"Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases","volume":"104","author":"Frank","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3389\/fimmu.2019.00276","article-title":"NLRP3 Inflammasome and Inflammatory Bowel Disease","volume":"10","author":"Zhen","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.cell.2011.04.022","article-title":"NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis","volume":"145","author":"Elinav","year":"2011","journal-title":"Cell"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.4049\/jimmunol.1402098","article-title":"The NLRP1 inflammasome attenuates colitis and colitis-associated tumorigenesis","volume":"194","author":"Williams","year":"2015","journal-title":"J. Immunol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.cell.2015.10.048","article-title":"Microbiota-Modulated Metabolites Shape the Intestinal Microenvironment by Regulating NLRP6 Inflammasome Signaling","volume":"163","author":"Levy","year":"2015","journal-title":"Cell"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.freeradbiomed.2016.11.011","article-title":"Regulation of the gut microbiome by inflammasomes","volume":"105","author":"Chen","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.immuni.2010.02.012","article-title":"Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases","volume":"32","author":"Yeretssian","year":"2010","journal-title":"Immunity"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1053\/j.gastro.2010.08.049","article-title":"A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes","volume":"139","author":"Willing","year":"2010","journal-title":"Gastroenterology"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"128Hu, B., Elinav, E., Huber, S., Strowig, T., Hao, L., Hafemann, A., Jin, C., Wunderlich, C., Wunderlich, T., and Eisenbarth, S.C. (2013). Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer. Proc. Natl. Acad. Sci. USA, 110, 9862\u20139867.","DOI":"10.1073\/pnas.1307575110"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.cell.2004.07.002","article-title":"Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis","volume":"118","author":"Paglino","year":"2004","journal-title":"Cell"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"7199","DOI":"10.1158\/0008-5472.CAN-13-0827","article-title":"Gut microbiota protects against gastrointestinal tumorigenesis caused by epithelial injury","volume":"73","author":"Zhan","year":"2013","journal-title":"Cancer Res."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1038\/s41467-017-01917-2","article-title":"Remodelling of the gut microbiota by hyperactive NLRP3 induces regulatory T cells to maintain homeostasis","volume":"8","author":"Yao","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1084\/jem.20100199","article-title":"MyD88-mediated signaling prevents development of adenocarcinomas of the colon: Role of interleukin 18","volume":"207","author":"Salcedo","year":"2010","journal-title":"J. Exp. Med."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"7187","DOI":"10.4049\/jimmunol.1100412","article-title":"A functional role for Nlrp6 in intestinal inflammation and tumorigenesis","volume":"186","author":"Chen","year":"2011","journal-title":"J. Immunol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1016\/j.celrep.2015.10.040","article-title":"The DNA Sensor AIM2 Maintains Intestinal Homeostasis via Regulation of Epithelial Antimicrobial Host Defense","volume":"13","author":"Hu","year":"2015","journal-title":"Cell Rep."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/cmi.2016.35","article-title":"The AIM2 inflammasome is a central regulator of intestinal homeostasis through the IL-18\/IL-22\/STAT3 pathway","volume":"14","author":"Ratsimandresy","year":"2017","journal-title":"Cell. Mol. Immunol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ni888","article-title":"Angiogenins: A new class of microbicidal proteins involved in innate immunity","volume":"4","author":"Hooper","year":"2003","journal-title":"Nat. Immunol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.autrev.2018.01.020","article-title":"NLRP3: A promising therapeutic target for autoimmune diseases","volume":"17","author":"Shen","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1515\/jomb-2016-0008","article-title":"NLRP3 and CARD8 Polymorphisms Influence Higher Disease Activity in Rheumatoid Arthritis","volume":"35","author":"Jenko","year":"2016","journal-title":"J. Med. Biochem."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/annrheumdis-2013-203276","article-title":"Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment","volume":"73","author":"Mathews","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"846782","DOI":"10.1155\/2015\/846782","article-title":"Role of genetic alterations in the NLRP3 and CARD8 genes in health and disease","volume":"2015","author":"Paramel","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1136\/ard.2004.025577","article-title":"Expression and regulation of cryopyrin and related proteins in rheumatoid arthritis synovium","volume":"64","author":"Rosengren","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s13075-015-0775-2","article-title":"Enhanced activity of NLRP3 inflammasome in peripheral blood cells of patients with active rheumatoid arthritis","volume":"17","author":"Choulaki","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/cei.12667","article-title":"Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1beta via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: A possible implication for therapeutic decision in these patients","volume":"182","author":"Ruscitti","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"ii3","DOI":"10.1093\/rheumatology\/keg326","article-title":"The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis","volume":"42","author":"Dayer","year":"2003","journal-title":"Rheumatology (Oxf.)"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.clim.2015.02.001","article-title":"Myeloid-derived suppressor cells are proinflammatory and regulate collagen-induced arthritis through manipulating Th17 cell differentiation","volume":"157","author":"Zhang","year":"2015","journal-title":"Clin. Immunol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"517","DOI":"10.4049\/jimmunol.166.1.517","article-title":"Reduced incidence and severity of collagen-induced arthritis in mice lacking IL-18","volume":"166","author":"Wei","year":"2001","journal-title":"J. Immunol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/cei.13167","article-title":"NLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis","volume":"194","author":"Guo","year":"2018","journal-title":"Clin. Exp. Immunol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.3899\/jrheum.090074","article-title":"Anakinra for rheumatoid arthritis: A systematic review","volume":"36","author":"Mertens","year":"2009","journal-title":"J. Rheumatol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3389\/fphar.2018.01157","article-title":"Anakinra Therapy for Non-cancer Inflammatory Diseases","volume":"9","author":"Cavalli","year":"2018","journal-title":"Front. Pharm."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nature13322","article-title":"Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis","volume":"512","author":"Jacques","year":"2014","journal-title":"Nature"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev-pathol-011110-130242","article-title":"Parkinson\u2019s disease: Genetics and pathogenesis","volume":"6","author":"Shulman","year":"2011","journal-title":"Annu. Rev. Pathol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev.biochem.75.101304.123901","article-title":"Protein misfolding, functional amyloid, and human disease","volume":"75","author":"Chiti","year":"2006","journal-title":"Annu. Rev. Biochem."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/S1353-8020(11)70008-6","article-title":"Misfolded alpha-synuclein and Toll-like receptors: Therapeutic targets for Parkinson\u2019s disease","volume":"18 Suppl 1","author":"Beraud","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Codolo, G., Plotegher, N., Pozzobon, T., Brucale, M., Tessari, I., Bubacco, L., and de Bernard, M. (2013). Triggering of inflammasome by aggregated alpha-synuclein, an inflammatory response in synucleinopathies. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0055375"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cell.2014.11.047","article-title":"Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome","volume":"160","author":"Yan","year":"2015","journal-title":"Cell"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"12504","DOI":"10.1038\/ncomms12504","article-title":"Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer\u2019s disease in rodent models","volume":"7","author":"Daniels","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/cns.12066","article-title":"Antimalarial drug artemisinin extenuates amyloidogenesis and neuroinflammation in APPswe\/PS1dE9 transgenic mice via inhibition of nuclear factor-kappaB and NLRP3 inflammasome activation","volume":"19","author":"Shi","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ni.3102","article-title":"Innate immunity in Alzheimer\u2019s disease","volume":"16","author":"Heneka","year":"2015","journal-title":"Nat. Immunol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni.1636","article-title":"The NALP3 inflammasome is involved in the innate immune response to amyloid-beta","volume":"9","author":"Halle","year":"2008","journal-title":"Nat. Immunol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"7745","DOI":"10.1074\/jbc.M708362200","article-title":"Inhibitors of cathepsin B improve memory and reduce beta-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, beta-secretase site of the amyloid precursor protein","volume":"283","author":"Hook","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nature"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00281-015-0518-0","article-title":"beta-amyloid, microglia, and the inflammasome in Alzheimer\u2019s disease","volume":"37","author":"Gold","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nri2550","article-title":"Autoimmune T cell responses in the central nervous system","volume":"9","author":"Goverman","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston","year":"2008","journal-title":"Lancet"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"974","DOI":"10.4049\/jimmunol.0904145","article-title":"NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses","volume":"185","author":"Gris","year":"2010","journal-title":"J. Immunol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/intimm\/dxh379","article-title":"Abnormal T cell activation caused by the imbalance of the IL-1\/IL-1R antagonist system is responsible for the development of experimental autoimmune encephalomyelitis","volume":"18","author":"Matsuki","year":"2006","journal-title":"Int. Immunol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.4049\/jimmunol.163.5.2403","article-title":"Caspase-1 regulates the inflammatory process leading to autoimmune demyelination","volume":"163","author":"Furlan","year":"1999","journal-title":"J. Immunol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.4049\/jimmunol.165.6.3099","article-title":"IL-18 directs autoreactive T cells and promotes autodestruction in the central nervous system via induction of IFN-gamma by NK cells","volume":"165","author":"Shi","year":"2000","journal-title":"J. Immunol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"10480","DOI":"10.1073\/pnas.1201836109","article-title":"NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis","volume":"109","author":"Inoue","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"15811","DOI":"10.1523\/JNEUROSCI.4088-10.2010","article-title":"The inflammasome sensor, NLRP3, regulates CNS inflammation and demyelination via caspase-1 and interleukin-18","volume":"30","author":"Jha","year":"2010","journal-title":"J. Neurosci."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.molimm.2014.10.008","article-title":"Increased inflammasome related gene expression profile in PBMC may facilitate T helper 17 cell induction in multiple sclerosis","volume":"63","author":"Peelen","year":"2015","journal-title":"Mol. Immunol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"4610","DOI":"10.4049\/jimmunol.1000217","article-title":"Cutting edge: Critical role for PYCARD\/ASC in the development of experimental autoimmune encephalomyelitis","volume":"184","author":"Shaw","year":"2010","journal-title":"J. Immunol."},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Dumas, A., Amiable, N., de Rivero Vaccari, J.P., Chae, J.J., Keane, R.W., Lacroix, S., and Vallieres, L. (2014). The inflammasome pyrin contributes to pertussis toxin-induced IL-1beta synthesis, neutrophil intravascular crawling and autoimmune encephalomyelitis. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1004150"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1742-2094-11-94","article-title":"Evaluating the levels of interleukin-1 family cytokines in sporadic amyotrophic lateral sclerosis","volume":"11","author":"Italiani","year":"2014","journal-title":"J. Neuroinflamm."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.mehy.2015.11.022","article-title":"In-situ expression of Interleukin-18 and associated mediators in the human brain of sALS patients: Hypothesis for a role for immune-inflammatory mechanisms","volume":"86","author":"Kadhim","year":"2016","journal-title":"Med. Hypotheses"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1002\/glia.22891","article-title":"NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients","volume":"63","author":"Johann","year":"2015","journal-title":"Glia"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"8429","DOI":"10.1007\/s12035-016-0322-4","article-title":"Administration of 17beta-Estradiol Improves Motoneuron Survival and Down-regulates Inflammasome Activation in Male SOD1 (G93A) ALS Mice","volume":"54","author":"Heitzer","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1742-2094-10-152","article-title":"Inflammasome induction in Rasmussen\u2019s encephalitis: Cortical and associated white matter pathogenesis","volume":"10","author":"Ramaswamy","year":"2013","journal-title":"J. Neuroinflamm."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S1474-4422(14)70137-1","article-title":"Controversies in HIV-associated neurocognitive disorders","volume":"13","author":"Nightingale","year":"2014","journal-title":"Lancet Neurol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1742-6405-11-13","article-title":"Viral and cellular factors underlying neuropathogenesis in HIV associated neurocognitive disorders (HAND)","volume":"11","author":"Rao","year":"2014","journal-title":"AIDS Res. Ther."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nrn3638","article-title":"Inflammasomes in the CNS","volume":"15","author":"Walsh","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1742-4690-11-35","article-title":"Rapid inflammasome activation in microglia contributes to brain disease in HIV\/AIDS","volume":"11","author":"Walsh","year":"2014","journal-title":"Retrovirology"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s11481-016-9708-3","article-title":"HIV-1 Viral Protein R Activates NLRP3 Inflammasome in Microglia: Implications for HIV-1 Associated Neuroinflammation","volume":"12","author":"Mamik","year":"2017","journal-title":"J. Neuroimmune Pharm."},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"Nuvolone, M., Sorce, S., Schwarz, P., and Aguzzi, A. (2015). Prion pathogenesis in the absence of NLRP3\/ASC inflammasomes. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0117208"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1742-2094-9-73","article-title":"The NALP3 inflammasome is involved in neurotoxic prion peptide-induced microglial activation","volume":"9","author":"Shi","year":"2012","journal-title":"J. Neuroinflamm."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/12\/4223\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:38:41Z","timestamp":1760175521000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/12\/4223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,13]]},"references-count":185,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,6]]}},"alternative-id":["ijms21124223"],"URL":"https:\/\/doi.org\/10.3390\/ijms21124223","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,13]]}}}